STL Volume 13 Number 3
Update on Drugs and Drug News – April 2008
Update on Peginterferon alfa-2b PEG-Intron™, Elesclomol (formerly STA-4783), Hyaluronic Acid Gel + Lidocaine Prevelle Silk™.
Advances in Pemphigus Therapy
The pemphigus variants represent a group of potentially life-threatening autoimmune mucocutaneous blistering diseases. Herein, we focus on the new and emerging therapies in the management of pemphigus.
Topical Therapy for the Management of Childhood Psoriasis: Part I
Psoriasis represents a potentially life-altering disease that can profoundly impact physical, emotional and social functioning, and overall quality of life. Part I of this 2-part series will focus on topical agents, their varying degrees of effectiveness, potential side-effects and applications in clinical practice.
